ID
24352
Description
Study part: Neurological Examination Week 4.An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.
Keywords
Versions (1)
- 7/30/17 7/30/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 30, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Neurological Examination Week 52 Ropinirole NCT00632736
Neurological Examination Week 52
- StudyEvent: ODM
Similar models
Neurological Examination Week 52
- StudyEvent: ODM
C0278060 (UMLS CUI [1,2])
C0016928 (UMLS CUI [1,2])
C0560184 (UMLS CUI [1,2])
C0242414 (UMLS CUI [1,2])
C0010268 (UMLS CUI [1,2])
C0026606 (UMLS CUI [1,2])
C0034929 (UMLS CUI [1,2])
C0682648 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,2])